Location History:
- Ontario, CA (2004 - 2007)
- Newmarket, CA (2002 - 2019)
Company Filing History:
5 out of 10 
4 out of 545 
3 out of 270 Years Active: 2002-2019
Title: The Innovative Contributions of Andrew Darke
Introduction
Andrew Darke is a notable inventor based in Newmarket, Canada, recognized for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, Darke has focused on developing advanced drug formulations that enhance therapeutic outcomes.
Latest Patents
Among his latest patents, Darke has developed controlled release formulations aimed at providing a rapid initial onset of effect along with a prolonged duration of effect. These oral modified/controlled release drug formulations are designed to ensure that the peak concentration of the drug is lower than that of immediate release formulations, while also allowing for a swift decline in effect at the end of the dosing interval. Additionally, he has worked on methods for treating attention deficit hyperactivity disorder, utilizing similar controlled release techniques to optimize treatment efficacy.
Career Highlights
Throughout his career, Andrew Darke has been associated with prominent companies in the pharmaceutical industry, including Rhodes Pharmaceuticals L.P. and Purdue Pharma L.P. His work has significantly impacted the development of innovative drug delivery systems.
Collaborations
Darke has collaborated with esteemed professionals in the field, including Thinnayam Naganathan Krishnamurthy and Paul D. Goldenheim, further enhancing the scope and impact of his inventions.
Conclusion
Andrew Darke's innovative work in drug formulation and delivery systems has made a lasting impact on the pharmaceutical industry. His contributions continue to pave the way for advancements in treatment methodologies.